Malaria prophylaxis using azithromycin: A double-blind, placebo- controlled trial in Irian Jaya, Indonesia

Clinical Infectious Diseases

Volumn 28, Issue 1, 1999, Pages 74-81

  Taylor, Walter R J ^a   Richie, Thomas L ^a   Fryauff, David J ^a   Picarima, Helena ^a   Ohrt, Colin ^a   Tang, Douglas ^a   Braitman, David ^a   Murphy, Gerald S ^a   Widjaja, Hendra ^a   Tjitra, Emiliana ^a   Ganjar, Asep ^a   Jones, Trevor R ^a   Basri, Hasan ^a   Berman, Josh ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; PLACEBO;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL;

EID: 0033033620     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515071     Document Type: Article

References (33)

1. World malaria situation in 1994. WHO. Wkly Epidemiol Rec 1997;72:269-76.
2. Warrell DA, Molyneux ME, Beales PF. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;(suppl 2)84:1-65.
3. World Health Organization. International travel and health: vaccine requirements and health advice. Geneva: World Health Organization, 1997:72-84.
4. World Health Organization. Antimalarial drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy [monograph on line]. Geneva: World Health Organization, 1994 [cited 14-18 March 1994]. WHO/MAL/94.1070.
5. Krogstad DJ. Malaria as a re-emerging disease. Epidemiol Rev 1996;18:77-89.
6. White NJ. Antimalarial drug resistance: the pace quickens. J Antimicrob Chemother 1992;30:571-85.
7. Kway MP, Oo M, Lwin M, Thawzin, Ave KH, Yin NN. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg 1993;87:687.
8. Murphy GS, Purnomo HB, Andersen EM, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993;341:96-100.
9. Health information for international travel. Washington, DC: US Government Printing Office. 1997.
10. Bradley DJ, Warhurst DC. Guidelines for the prevention of malaria in travellers from the United Kingdom. Commun Dis Rep CDR Rev 1997;7:R137-52.
11. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 1996;14:131-45.
12. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimes in tourists visiting East Africa. Lancet 1993;431:1299-303.
13. Weiss W, Oloo AJ, Johnson A, Koech D, Hoffman S. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis 1995;171:1569-75.
14. Andersen SL, Berman J, Kuschner R, et al. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med 1995;123:771-3.
15. Kuschner RA, Heppner DG, Andersen SL, et al. Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum. Lancet 1994;343:1396-7.
16. Sadiq ST, Glasgow KW, Drakeley CJ, et al. Effects of azithromycin on malariometric indices in The Gambia. Lancet 1995;346:881-2.
17. Andersen SL, Oloo AJ, Gordon DM, et al. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clin Infect Dis 1998;26:146-50.
18. Physicians' desk reference. Azithromycin product information. Oradell, New Jersey: Medical Economics, 1997:2043-50.
19. Ohrt C, Richie TL, Widjaja H, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. Ann Intern Med 1997;126:963-72.
20. Hoffman SL, Dimpudus AJ, Campbell JR, et al. RII and RIII type resistance of Plasmodium falciparum to the combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia. Lancet 1985;2:1039-40.
21. Ebisawa I, Fukuyuma T. Chloroquine-resistant Plasmodium falciparum from West Irian and East Kalimantan. Ann Trop Med Hyg 1975;69:131.
22. Baird JK, Basri H, Jones TR, Purnomo, Bangs MJ, Rotonga A. Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia. Am J Trop Med Hyg 1991;44:640-4.
23. Mewissen JHET. Resistance of Plasmodium falciparum to pyrimethamine and proguanil in Netherlands New Guinea. Am J Trop Med 1961;10:135-9.
24. Baird JK, Basri H, Subianto B, et al. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 1995;17:1678-82.
25. Jones TR, Baird K, Bangs MJ, et al. Malaria vaccine study site in Irian Jaya, Indonesia: Plasmodium falciparum incidence measurements and epidemiological considerations in sample size estimation. Am J Trop Med Hyg 1994;50:210-8.
26. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990;9:1447-54.
27. Shute GT. The microscopic diagnosis of malaria. In: Wernsdorfer WH, McGregor I, eds. Malaria: principles and practice of malariology. Edinburgh: Churchill Livingstone, 1988:781-814.
28. Ederer F, Mantel N. Confidence limits on the ratio of two Poisson variables. Am J Epidemiol 1974;100:165-7.
29. Koopman PA. Confidence limits on the ratio of two proportions. Biometrics 1984;40:513-7.
30. Lee ET. Statistical methods for survival data analysis. 2nd ed. New York: Wiley, 1992:109-12.
31. Altman DG. Practical statistics for medical research. New York: Chapman & Hall, 1991.
32. Baird JK. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitology Today 1995;11:105-11.
33. Zuckerman JM, Kaye KM. The newer macrolides. Infect Dis Clin North Am 1995;9:731-45.